Track topics on Twitter Track topics that are important to you
Celyad SA licensed Novartis AG nonexclusive rights to its patents related to the production of allogeneic CAR-T cells.
Original Article: Celyad licenses CAR-T patents to NovartisNEXT ARTICLE
Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosi...